Live from the NIH registry
Studies recruiting near Jacksonville right now
Top 25 of 893 recruiting studies, sorted by proximity — each links to its official registry page
A Study to Investigate the Safety and Efficacy of SAR446523 Injected Subcutaneously in Adult Participants With Relapsed/Refractory Myeloma
Plasma Cell Myeloma Refractory
Phase 1
Interventional 87 participants sought
Mayo Clinic in Florida- Site Number : 8400003 — Jacksonville, Florida (1.1 mi)
· Sponsor: Sanofi
A Study to Compare the PK Characteristics, Safety, Tolerability, and Immunogenicity of HLX15-SC With DARZALEX FASPRO® in Combination With Lenalidomide and Dexamethasone (Rd) in Transplant-ineligible Patients With Newly Diagnosed Multiple Myeloma
Multiple Myeloma (MM)
Phase 1
Interventional 258 participants sought
Cancer Specialists of North Florida — Jacksonville, Florida (1.1 mi)
· Sponsor: Shanghai Henlius Biotech
Fibromyalgia Response With Esreboxetine Evaluated Using a Randomized Withdrawal Research Design
Fibromyalgia
Phase 3
Interventional 620 participants sought
Clinical Research Site — Jacksonville, Florida (1.1 mi)
· Sponsor: Axsome Therapeutics, Inc.
Clinical Study of a Vaginal Cooling Device for the Treatment of Vulvovaginal Candidiasis (VVC)
Vulvovaginal Candidiasis (VVC), Yeast Vaginitis
N/A
Interventional 55 participants sought
Symphony Clinical Research — Jacksonville, Florida (1.1 mi)
· Sponsor: Coologics, Inc
Lp(a) Lowering Study of Pelacarsen (TQJ230) With Background Inclisiran in Participants With Elevated Lp(a) and Established ASCVD
Atherosclerotic Cardiovascular Disease (ASCVD)
Phase 3
Interventional 340 participants sought
Jacksonville Center for Clinical — Jacksonville, Florida (1.1 mi)
· Sponsor: Novartis Pharmaceuticals
A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee Osteoarthritis Lose Weight and Reduce Pain
Obesity, Knee Osteoarthritis (OA)
Phase 3
Interventional 400 participants sought
CNS Healthcare — Jacksonville, Florida (1.1 mi)
· Sponsor: Novo Nordisk A/S
Study of AZD4512 Monotherapy or in Combination With Anticancer Agents in Participants With Acute Lymphoblastic Leukemia
B-cell Acute Lymphoblastic Leukemia (B-ALL)
Phase 1, Phase 2
Interventional 83 participants sought
Research Site — Jacksonville, Florida (1.1 mi)
· Sponsor: AstraZeneca
Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant
Amyloidosis, Amyloid Cardiomyopathy
Phase 3
Interventional 587 participants sought
Mayo Clinic - Jacksonville — Jacksonville, Florida (1.1 mi)
· Sponsor: Eidos Therapeutics, a BridgeBio company
Evaluating the Association Among Changes in Gut Microbiome, Fatigue, and Chemotherapy-Induced Nausea in Early Stage Breast Cancer
Chemotherapy-Related Nausea and/or Vomiting, Early Stage Breast Carcinoma
N/A
Observational 70 participants sought
Mayo Clinic in Florida — Jacksonville, Florida (1.1 mi)
· Sponsor: Mayo Clinic
Longitudinal Early-onset Alzheimer's Disease Study Protocol
Early Onset Alzheimer Disease, Alzheimer Disease
N/A
Observational 850 participants sought
Mayo Clinic, Jacksonville — Jacksonville, Florida (1.1 mi)
· Sponsor: Indiana University
An Extension Study for Patients Previously Enrolled in Studies With Pelabresib
Hematologic Malignancy, Solid Tumor
Phase 3
Interventional 50 participants sought
Mayo Clinic Jacksonville — Jacksonville, Florida (1.1 mi)
· Sponsor: Novartis Pharmaceuticals
A Study to Evaluate Efficacy and Safety of MELT-300 for Procedural Sedation in Subjects Undergoing Cataract Extraction With Lens Replacement (CELR)
Cataract
Phase 3
Interventional 528 participants sought
Levenson Eye Associates — Jacksonville, Florida (1.1 mi)
· Sponsor: Melt Pharmaceuticals
Study of XmAb942 in Healthy Participants and Participants With Ulcerative Colitis
Ulcerative Colitis (UC)
Phase 1, Phase 2
Interventional 270 participants sought
Xencor Investigative Site — Jacksonville, Florida (1.1 mi)
· Sponsor: Xencor, Inc.
A Phase 1 Clinical Study of NXP900 in Subjects With Advanced Cancers
Advanced Solid Tumor, NSCLC (Non-small Cell Lung Cancer)
Phase 1
Interventional 140 participants sought
Mayo Clinic — Jacksonville, Florida (1.1 mi)
· Sponsor: Nuvectis Pharma, Inc.
Diaphragmatic Breathing for the Treatment of Bloating and Distension
Bloating
N/A
Interventional 35 participants sought
Mayo Clinic in Florida — Jacksonville, Florida (1.1 mi)
· Sponsor: Mayo Clinic
Long-Term Safety of Lutetium (177Lu) Vipivotide Tetraxetan in Participants With Prostate Cancer
Prostate Cancer
Phase 4
Interventional 700 participants sought
Mayo Clinic Jacksonville — Jacksonville, Florida (1.1 mi)
· Sponsor: Novartis Pharmaceuticals
A Study of Eltrekibart and Mirikizumab in Adult Patients With Moderately to Severely Active Ulcerative Colitis
Ulcerative Colitis, Ulcerative Colitis Chronic
Phase 2
Interventional 140 participants sought
Digestive Disease Consultants DDCJAX — Orange Park, Florida (11.6 mi)
· Sponsor: Eli Lilly and Company
Building Community Living Labs in Black Communities to Advance Prostate Health Equity and Reduce Prostate Cancer Disparities in Black Men
Prostate Carcinoma
N/A
Interventional 250 participants sought
Mayo Clinic in Florida — Jacksonville, Florida (1.1 mi)
· Sponsor: Mayo Clinic
BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study
Multiple conditions
Phase 2
Interventional 150 participants sought
Mayo Clinic in Florida — Jacksonville, Florida (1.1 mi)
· Sponsor: National Cancer Institute (NCI)
IVM With Low Cost Priming, Enhanced Oocyte Recovery, and Delayed Transfer
Polycystic Ovary Syndrome
N/A
Interventional 300 participants sought
Brown Fertility — Jacksonville, Florida (1.1 mi)
· Sponsor: Bruce Rose, MD
A Study to Investigate Safety and Efficacy of Tapinarof Cream, 1% in Participants Ages 3 Months to < 24 Months With Atopic Dermatitis
Atopic Dermatitis
Phase 3
Interventional 180 participants sought
APEX Clinical Trials — Jacksonville, Florida (1.1 mi)
· Sponsor: Organon and Co
Avacopan in Crescentic Immunoglobulin A Nephropathy (IgAN)
IgA Nephropathy (IgAN)
Phase 2
Interventional 16 participants sought
Mayo Clinic in Florida — Jacksonville, Florida (1.1 mi)
· Sponsor: Mayo Clinic
Pre-myeloid Cancer and Bone Marrow Failure Clinic Study
Myeloid Malignancy, Inherited Bone Marrow Failure Syndrome
N/A
Interventional 2,000 participants sought
Mayo Clinic in Florida — Jacksonville, Florida (1.1 mi)
· Sponsor: Mayo Clinic
Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma
Ganglioneuroblastoma, Nodular, Neuroblastoma
Phase 3
Interventional 478 participants sought
Nemours Children's Clinic-Jacksonville — Jacksonville, Florida (1.1 mi)
· Sponsor: National Cancer Institute (NCI)
Phase III, Open-label Study of First-line Osimertinib With or Without Datopotamab Deruxtecan for EGFRm Locally Advanced or Metastatic Non-small Cell Lung Cancer
Non-small Cell Lung Cancer
Phase 3
Interventional 582 participants sought
Research Site — Jacksonville, Florida (1.1 mi)
· Sponsor: AstraZeneca